All News

Top news of the week from Specialty Pharmacy Times.

Ashir Shumonov, PharmD, talks about his residency at the Veterans Affairs Veterans Integrated Service Network 17 pharmacy benefits manager.

Do not let the naysayers discourage you from pursuing your dreams.

Many factors influence whether a specialty pharmacy can gain access to limited distribution drug networks.

T-cells modified to express dominant-negative TGF-β receptor type 2 overcame cancer cell defenses.

An immunomodulatory cytokine interacts with its receptors differently than other cytokines.

An obesity drug may reduce the risk of metastatic prostate cancer.

Agencies send warning letters to companies selling products with unsubstantiated claims about treating opioid misuse disorder.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

FDA seeks to change policies to ensure balance between the need to preserve access and ensure safety of appropriately compounded drugs for patients whose needs cannot be met by FDA-approved products.

Officials with the FDA have approved plecanatide (Trulance, Synergy) for the once-daily treatment of irritable bowel syndrome with constipation (IBS-C) in adults.

Chronic pain patient may respond to endogenous opioids differently than healthy people.

In this article I hope to open a discussion on the current “wasting” of narcotics by purposely disposing in sink drains.

Follow these tips to improve your patient's lifestyle choices.

Experts are finding, though, that burnout doesn't limit its impact to the workplace. It also impacts parts of your life that extend well beyond the pharmacy.

Pharmacists not only have a great responsibility to stay current with new medications, but also with the laws governing the profession.

Officials with the FDA and the Federal Trade Commission (FTC) today issued joint warnings to companies selling unapproved opioid cessation products with deceptive claims about their ability to treat opioid addiction and withdrawal.

Erenumab observed to reduce monthly migraine days.

Gene expression may lead to castration-resistant prostate cancer.

Patients may be less likely to undergo a blood test to diagnose HIV.

A multiple sclerosis drug may be used as a PET scan tracer agent to image demyelination.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment.

Patients with Parkinson disease who have a specific genetic mutation show a slower decline in motor functioning compared to patients without the mutation.

When frontline pharmacists are trained to provide travel health services, they can expand access to patients due to their convenience.

Vector-based gene therapy shows efficacy treating glaucoma.

Sen Bill Cassidy, MD (R-LA), proposes legislation that would require hospitals to pass 340B savings on to patients.